A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial
Conditions
ANCA Associated Vasculitis · Rapidly Progressive Glomerulonephritis · Crescentic Glomerulonephritis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU Amiens, Amiens, France
CHU d'Angers, Angers, France
CH de Boulogne sur Mer, Boulogne-sur-Mer, France
CHU Brest - Hôpital de la Cavale Blanche, Brest, France
CHU de Dijon, Dijon, France
CHU de Grenoble - Hôpital Michalon site nord, Grenoble, France
Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
Hopital Le Kremlin Bicetre - Aphp, Le Kremlin-Bicêtre, France
AP-HM - Hôpital la Conception, Marseille, France
CHU de Nantes - Hotel Dieu, Nantes, France
CHU Pasteur 2 - Nice, Nice, France
CHU Nîmes - Hôpital universitaire Caremeau, Nîmes, France
AP-HP - Hôpital Cochin, Paris, France
AP-HP - Necker enfants malades, Paris, France
HEGP, Paris, France
AP-HP - Hôpital Bichat, Paris, France
AP-HP - Tenon, Paris, France
AP-HP - Henri Mondor, Paris, France
AP-HP - Hôpital Ambroise-Paré, Paris, France
CHU de Rouen, Rouen, France
CHU de Strasbourg, Strasbourg, France
CHU de Toulouse - Hôpital Rangueil, Toulouse, France
CH Valenciennes, Valenciennes, France
Contact: Study coordinator (Cyrille Vandenbussche) · vandenbussche-c@ch-valenciennes.fr · +33 3 27 14 30 89Chru de Nancy, Vandœuvre-lès-Nancy, France
Hôpital Robert Schuman (UNEOS), Vantoux, France
Study leads
Alexandre Karras
Principal Investigator
Assistance Publique - Hôpitaux de Paris